Sign In
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- US Share Prices
- Stock Tips
- Share Chat
- FX
- News & RNS
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
Hikma Pharmaceuticals Share News (HIK)
HIK Share
Price
HIK Share
News
HIK Share
Chat
HIK Share
Trades912
HIK
Live RNS
HIK Share
Charts
HIK Level 2
Console
HIK Live
Share Price
HIK Broker
Ratings
HIK Directors
Deals
HIK Financial
Diary
HIK
Fundamentals
HIK Short
Positions2
HIK
Media
HIK Company
Research
HIK Company
Timeline2
Hikma Pharmaceuticals Information
Share Price Information for Hikma Pharmaceuticals (HIK)
Share Price is delayed by 15 minutes
Get Live Data
1,531.00
1.00 (0.07%)
Bid:
1,531.00
Ask:
1,532.00
Spread:
1.00 (0.065%)
Market Cap:
£3.22b
Last checked at -
Last checked at 
Intraday Hikma Pharmaceuticals Share Chart
Hikma Pharmaceuticals News
18 Dec 2019
Moody's Affirms All Hikma's Ratings, Outlook Stable
Moody's Affirms All Hikma's Ratings, Outlook Stable
3 Dec 2019
UK BROKER RATINGS SUMMARY: Barclays Likes Primary Health And Assura
UK BROKER RATINGS SUMMARY: Barclays Likes Primary Health And Assura
27 Nov 2019
TOP NEWS: Hikma Submits Response To Advair Application Deficiencies
TOP NEWS: Hikma Submits Response To Advair Application Deficiencies
27 Nov 2019
LONDON MARKET PRE-OPEN: BAT Sees Strong 2019 Despite US Vape Slowdown
LONDON MARKET PRE-OPEN: BAT Sees Strong 2019 Despite US Vape Slowdown
27 Nov 2019
Hikma responds to FDA concerns over 'Advair Diskus' generic
(Sharecast News) - Hikma Pharmaceuticals has submitted its response to deficiencies in its abbreviated new drug application for a generic version of G...
13 Nov 2019
LONDON BRIEFING: SSE Raises Outlook But Cuts Dividend 18% As Planned
LONDON BRIEFING: SSE Raises Outlook But Cuts Dividend 18% As Planned
7 Nov 2019
LONDON MARKET MIDDAY: US-China Hopes Boost Market; BOE Holds UK Rates
LONDON MARKET MIDDAY: US-China Hopes Boost Market; BOE Holds UK Rates
7 Nov 2019
Hikma Pharmaceuticals Keeps 2019 Guidance As All Units Deliver Growth
Hikma Pharmaceuticals Keeps 2019 Guidance As All Units Deliver Growth
Follow the stocks
